Multidisciplinary management of advanced lung neuroendocrine tumors. - Test2 - elhamkhani - TriplyDB

Multidisciplinary management of advanced lung neuroendocrine tumors.

Multidisciplinary management of advanced lung neuroendocrine tumors.

http://www.wikidata.org/entity/Q38487554

about

Do we really care about incidental lung nodules?-Review of atypical lung carcinoid and a proposal for systematic patient follow up Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)

P2860

Q33890530-C9772F98-0CB0-429C-A9A2-59356B095E6B Q37725971-436F24C0-EE15-4142-A288-64C1F6D1D6ED Q38651086-F7A8B93D-A945-4693-921B-E2B69CC2AC61 Q38743093-F48F0E95-AD6D-42C7-A1AA-5B0EDC3E9C4F Q45071563-9E3EF1BA-CA49-4E54-8255-F865C18AB111 Q48152898-D374FE87-851D-476C-888A-DEB70540EBD7 Q58693427-A8157AAD-C4B6-4842-ABCE-EFF245C097B0 Q58696921-5E990022-1EF9-4A5B-8F87-B35723138218

P2860

Multidisciplinary management of advanced lung neuroendocrine tumors.

http://www.wikidata.org/entity/Q38487554

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Multidisciplinary management of advanced lung neuroendocrine tumors.

@en

type

label

Multidisciplinary management of advanced lung neuroendocrine tumors.

@en

prefLabel

Multidisciplinary management of advanced lung neuroendocrine tumors.

@en

P1433

Q38487554-8FCB15C8-9E43-4C20-9418-35A8AC412D1D

P1476

Q38487554-7CDC4AD4-E933-474B-B359-FE9ABB2E80C9

P2093

Q38487554-3634D632-80F7-4C54-9840-1892DBC5ABAB

Q38487554-43895EBF-560A-49C8-B70A-4F19F8D240D9

P2860

Q38487554-00742F30-5E23-48B1-93AF-49DEA5F726CD

Q38487554-022DF17D-8FE6-4428-9CB0-0FD4F4A657A5

Q38487554-028BEB49-64A5-40F2-9AC0-E7EC134F0052

Q38487554-1A772128-26F2-4BCA-B102-272A0BCB21F1

Q38487554-1FEDC9F2-5EA0-4724-A1A3-2447549EE9D4

Q38487554-2134E786-D4D3-4A8A-8BE1-72EF7E63E2AE

Q38487554-250F0766-7121-4A66-9DFB-7021F4AE1B8B

Q38487554-2638286D-52A9-47F1-A175-F04F8A4FA08C

Q38487554-2C1BFF66-04D1-46F9-A703-C84A80F2CD43

Q38487554-357917A0-DC02-41AB-A92A-A0D0900AD7E6

P304

Q38487554-9A72BE08-2491-4BF3-9FD3-B049FB2D74D1

P31

Q38487554-9C4BDA38-CF27-4536-9540-AE21DCF04D76

P356

Q38487554-64400A2A-54DE-4101-8088-F915BC275095

P433

Q38487554-C4D98772-37CF-418F-9BC2-E2579F40702F

P478

Q38487554-2ABE8FD1-257C-4CD7-990A-F5D5943D65B8

P50

Q38487554-16581532-74B4-4DE1-9C4F-952FDFDCE2EB

Q38487554-18F0381F-1F36-4D46-8C6A-FF004B0C2778

Q38487554-21B2D84E-0632-4B89-A8CE-DB6F4EDD3DDE

Q38487554-2475DA57-D55A-4E5C-8F33-C1F46ABB7749

Q38487554-6B97F532-3FC9-4266-B6EF-C208D955B448

Q38487554-97DBD164-7503-4043-8EEB-2086EFD661BE

Q38487554-E8A47EC4-F297-4F77-83B3-FC7EE96B22ED

P577

Q38487554-64844506-369D-4EBA-8484-7B595494E82D

P5875

Q38487554-98B7DA08-D490-4C27-9991-662382D92012

P698

Q38487554-79D30833-275D-44FF-9FD2-B0B9D55BB241

P932

Q38487554-9A9D66AB-062D-439D-A2D7-7CB04FFC5C76

P356

J.ISSN.2072-1439.2015.04.20

P1433

Journal of thoracic disease

P1476

Multidisciplinary management of advanced lung neuroendocrine tumors

@en

P2093

European Society of Thoracic S ...... rking-Group Steering Committee

http://www.w3.org/2001/XMLSchema#string

William D Travis

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Effect of temozolomide in patients with metastatic bronchial carcinoids.

Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties.

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.

A 5-decade analysis of 13,715 carcinoid tumors.

Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.

Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.

Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors.

P304

S163-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2072-1439.2015.04.20

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Pier Luigi Filosso

Francesco Guerrera

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276849981

http://www.w3.org/2001/XMLSchema#string

P698

25984363

http://www.w3.org/2001/XMLSchema#string

P932

4419025

http://www.w3.org/2001/XMLSchema#string